← back to search

Claudio Viscoli

University of Lausanne · CH
Area of research
Infectious Diseases · Oncology
Research interest
Research focused on Micafungin and Voriconazole, with related work in Fluconazole, Guideline, Caspofungin. Notable publications include 'Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group...', 'Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline', and 'ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients'.
h-index
citations
9,002
works
17
NIH funding
primary concept
email

Recent publications

<i>Pneumocystis jirovecii</i>Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus
Clinical Infectious Diseases 2020cited by 128position: middledoi
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
Clinical Infectious Diseases 2019cited by 2,757position: middledoi
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2019cited by 908position: middledoi
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients
Intensive Care Medicine 2019cited by 112position: middledoi
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Clinical Microbiology and Infection 2018cited by 1,502position: middledoi
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
Clinical Infectious Diseases 2018cited by 350position: middledoi
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial
Clinical Infectious Diseases 2018cited by 178position: middledoi
Procalcitonin-guided antibiotic therapy: an expert consensus
Clinical Chemistry and Laboratory Medicine (CCLM) 2018cited by 81position: middledoi
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study
Intensive Care Medicine 2017cited by 75position: lastdoi
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality
Transplantation Direct 2017cited by 52position: lastdoi
International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus
Drug Resistance Updates 2015cited by 328position: middledoi
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts
Intensive Care Medicine 2013cited by 191position: middledoi
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
Clinical Microbiology and Infection 2012cited by 1,211position: middledoi
ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures
Clinical Microbiology and Infection 2012cited by 394position: middledoi
ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
Clinical Microbiology and Infection 2012cited by 360position: middledoi
ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
Clinical Microbiology and Infection 2012cited by 335position: middledoi
Safety and Tolerability of Voriconazole in Patients with Baseline Renal Insufficiency and Candidemia
Antimicrobial Agents and Chemotherapy 2012cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Matteo Bassetti · Istituto Nazionale di Fisica Nucleare, Sezione di Genova7 papers (2012–2019)Bart Jan Kullberg · Radboud University Nijmegen7 papers (2012–2018)Andreas H. Groll · TU Dortmund University6 papers (2012–2020)Emmanuel Roilides · The Royal Melbourne Hospital5 papers (2012–2013)Raoul Herbrecht · Amgen (United States)5 papers (2012–2018)Paul E. Verweij · Radboud University Nijmegen5 papers (2012–2015)Oliver A. Cornely · Agostino Gemelli University Polyclinic5 papers (2012–2015)J. Peter Donnelly · Baylor College of Medicine5 papers (2012–2015)Maiken Cavling Arendrup · Statens Serum Institut5 papers (2012–2015)Manuel Cuenca‐Estrella · Instituto de Salud Carlos III4 papers (2012–2012)Andrew J. Ullmann · Johannes Gutenberg University Mainz4 papers (2012–2012)Elio Castagnola · Istituto Giannina Gaslini4 papers (2012–2012)Henrik Elvang Jensen · University of Copenhagen4 papers (2012–2012)Sevtap Arıkan-Akdağlı · Hacettepe University4 papers (2012–2012)Malcolm Richardson · Manchester Academic Health Science Centre4 papers (2012–2012)Murat Akova · Hacettepe University Hospital4 papers (2012–2012)William Hope · University of Liverpool4 papers (2012–2012)Olivier Lortholary · Institut Pasteur4 papers (2012–2012)Cornelia Lass‐Flörl · Innsbruck Medical University4 papers (2012–2012)Jacques Billé · University of Lausanne4 papers (2012–2012)